Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Schaefer

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Birth Defects Research. Part A, Clinical and Molecular Teratology|November 25, 2003
Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicityChristof Schaefer
JAMA|July 2, 2016
Characteristics of Patients Dying With Cancer in Developed CountriesChristof Schaefer
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 11, 2018
[Drug safety in pregnancy-a particular challenge]Christof Schaefer
Congenital Anomalies|December 17, 2010
Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information ServicesChristof Schaefer
Clinical Advances in Hematology & Oncology : H&O|December 7, 2006
Exposure to vitamin K antagonists during pregnancyChristof Schaefer
European Journal of Clinical Pharmacology|October 25, 2017
Drug safety in pregnancy: the German Embryotox instituteKatarina Dathe, Christof Schaefer
Deutsches Arzteblatt International|January 11, 2020
The Use of Medication in PregnancyKatarina Dathe, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)|July 16, 2008
Statistical methods for estimating the probability of spontaneous abortion in observational studies--analyzing pregnancies exposed to coumarin derivativesReinhard Meister, Christof Schaefer
Deutsches Arzteblatt International|April 29, 2020
In ReplyKatarina Dathe, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)|June 24, 2008
The safety of cetirizine during pregnancy. A prospective observational cohort studyCorinna Weber-Schoendorfer, Christof Schaefer
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Birth Defects Research. Part A, Clinical and Molecular Teratology|November 25, 2003
Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicityChristof Schaefer
JAMA|July 2, 2016
Characteristics of Patients Dying With Cancer in Developed CountriesChristof Schaefer
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 11, 2018
[Drug safety in pregnancy-a particular challenge]Christof Schaefer
Congenital Anomalies|December 17, 2010
Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information ServicesChristof Schaefer
Clinical Advances in Hematology & Oncology : H&O|December 7, 2006
Exposure to vitamin K antagonists during pregnancyChristof Schaefer
European Journal of Clinical Pharmacology|October 25, 2017
Drug safety in pregnancy: the German Embryotox instituteKatarina Dathe, Christof Schaefer
Deutsches Arzteblatt International|January 11, 2020
The Use of Medication in PregnancyKatarina Dathe, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)|July 16, 2008
Statistical methods for estimating the probability of spontaneous abortion in observational studies--analyzing pregnancies exposed to coumarin derivativesReinhard Meister, Christof Schaefer
Deutsches Arzteblatt International|April 29, 2020
In ReplyKatarina Dathe, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)|June 24, 2008
The safety of cetirizine during pregnancy. A prospective observational cohort studyCorinna Weber-Schoendorfer, Christof Schaefer
Pageof 10